35 filings
424B5
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Prospectus supplement for primary offering
4:01pm
F-3
ENLV
Enlivex Therapeutics Ltd
29 Apr 22
Shelf registration (foreign)
8:14am
S-8
ENLV
Enlivex Therapeutics Ltd
4 Jun 21
Registration of securities for employees
4:16pm
424B5
ENLV
Enlivex Therapeutics Ltd
10 Feb 21
Prospectus supplement for primary offering
5:22pm
FWP
ENLV
Enlivex Therapeutics Ltd
10 Feb 21
Free writing prospectus
6:08am
F-3MEF
5ol1k zm431rxg42r6
9 Feb 21
Registration statement to add securities to prior F-3 registration
9:40pm
FWP
cgg7u4 plr846rn
9 Feb 21
Free writing prospectus
5:21pm
424B5
ack rjgz7hmgesh
9 Feb 21
Prospectus supplement for primary offering
4:56pm
424B5
l054crbsduuctypt
22 Oct 20
Prospectus supplement for primary offering
8:45am
424B5
qt5y1
3 Mar 20
Prospectus supplement for primary offering
5:13pm
424B5
23v1gr 8ftp
26 Feb 20
Prospectus supplement for primary offering
8:23am
424B5
v4s 75yu5999
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
gwq6n42607x7 xe
10 Jul 19
Prospectus supplement
8:18am
F-3
j5wkjgbrg1b8zwy
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
a1fq5gc
7 Jun 19
Shelf registration (foreign)
3:31pm
RW
g5gbgxntn
6 Apr 17
Registration withdrawal request
12:00am
F-1/A
x9peydgr62yl
6 Apr 17
Registration statement (foreign) (amended)
12:00am
F-1/A
2u1ao6t1n i1yu4ewdd3
5 Apr 17
Registration statement (foreign) (amended)
12:00am
F-1/A
v0duazg4lcw6ztxv 8m2
4 Apr 17
Registration statement (foreign) (amended)
12:00am
F-1/A
9ao 42h1dd
16 Mar 17
Registration statement (foreign) (amended)
12:00am